Article Type
Article
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Medicare vs VA—VA Wins; Delaying Antibiotics for UTI; Dolutegravir Approved to Treat Resistant HIV Infection

Article PDF
030100034.pdf
Author and Disclosure Information

Issue
Federal Practitioner - 30(10)
Publications
Federal Practitioner
Topics
HIV
Sexual Health
Page Number
34-35
Legacy Keywords
medicare, brand name vs generic, pharmaceutical expenditures, urinary tract infection antibiotics, UTI, dolutegravir, HIV drug
Sections
Pharmacology
Author and Disclosure Information

Author and Disclosure Information

Article PDF
030100034.pdf
Article PDF
030100034.pdf

Issue
Federal Practitioner - 30(10)
Issue
Federal Practitioner - 30(10)
Page Number
34-35
Page Number
34-35
Publications
Federal Practitioner
Publications
Federal Practitioner
Topics
HIV
Sexual Health
Article Type
Article
Display Headline
Medicare vs VA—VA Wins; Delaying Antibiotics for UTI; Dolutegravir Approved to Treat Resistant HIV Infection
Display Headline
Medicare vs VA—VA Wins; Delaying Antibiotics for UTI; Dolutegravir Approved to Treat Resistant HIV Infection
Legacy Keywords
medicare, brand name vs generic, pharmaceutical expenditures, urinary tract infection antibiotics, UTI, dolutegravir, HIV drug
Legacy Keywords
medicare, brand name vs generic, pharmaceutical expenditures, urinary tract infection antibiotics, UTI, dolutegravir, HIV drug
Sections
Pharmacology
Article Source

PURLs Copyright

Inside the Article

Article PDF Media